tirzepatide shortage Trade group sues FDA over ending Mounjaro/Zepbound Tirzepatide Update: On December 19th

There's a stigma around obesity that its due to sloth and gluttony and thats just not true for most people who are obese

In addition to excessive expenditure on health care, obesity also imposes costs in the form of lost productivity at work, mortality, and permanent disability

Conflicts of interest There are no conflicts of interest

The drug has been studied in human trials, including a Phase 2 trial published in The Lancet in 2008 and a Phase 3 trial in 372 patients in Mexico, but a dedicated cardiovascular outcomes trial that US and EU regulators would expect has not been run

Some patients also report nausea or GI discomfort when dosing intervals become irregular

"Consumers need to understand that the safety of compounded medicines are not assessed by the TGA, and they are not subject to the same controls over the quality or efficacy of the goods when compared with medicines approved for supply in Australia." The ABC understands the action is part of a wider probe examining whether compounding pharmacies were illegally mass producing compounded weight loss medications